Following the addition of Acalabrutinib (BTK inhibitor), Enzastaurin (PKCβ inhibitor), or SR/T5 to the co‐culture, CLL cell survival was analyzed in the peripheral and core regions of the 3D culture system using flow cytometry (Figure 6D). Here, PRKCB is linked to B-cell chronic lymphocytic leukemia.